Table of Contents USA Ophthalmic Therapeutic Drugs Market Report 2012-2023 1 Ophthalmic Therapeutic Drugs Overview 1.1 Product Overview and Scope of Ophthalmic Therapeutic Drugs 1.2 Classification of Ophthalmic Therapeutic Drugs by Product Category 1.2.1 USA Ophthalmic Therapeutic Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 by Therapeutic Class 1.2.4 Anti-inflammatory Drugs 1.2.5 Anti-infective Drugs 1.2.6 Anti-glaucoma Drugs 1.2.7 Anti-allergy Drugs 1.2.8 Anti-VEGF Agents 1.2.9 ????????Others 1.2.10 ????by Product Type 1.2.11 ????????Prescription Drugs 1.2.12 ????????Over-the-Counter Drugs 1.3 USA Ophthalmic Therapeutic Drugs Market by Application/End Users 1.3.1 USA Ophthalmic Therapeutic Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.3.4 Independent Pharmacies & Drug Stores 1.4 USA Ophthalmic Therapeutic Drugs Market by Region 1.4.1 USA Ophthalmic Therapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Ophthalmic Therapeutic Drugs (2012-2023) 1.5.1 USA Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Ophthalmic Therapeutic Drugs 2.2 Raw Material Analysis of Ophthalmic Therapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Ophthalmic Therapeutic Drugs 2.4 Other Costs Analysis of Ophthalmic Therapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Ophthalmic Therapeutic Drugs 2.6 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs 2.7 Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Ophthalmic Therapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Bayer 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Bayer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Bayer Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Bayer Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.2 Pfizer 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Pfizer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Pfizer Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 Pfizer Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Novartis Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Novartis Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 Novartis Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.4 ALLERGAN 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 ALLERGAN Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 ALLERGAN Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Aerie Pharmaceuticals 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Aerie Pharmaceuticals Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Valeant Pharmaceuticals International 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Valeant Pharmaceuticals International Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Genentech 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Genentech Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Genentech Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Genentech Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.8 Regeneron Pharmaceuticals 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Regeneron Pharmaceuticals Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.9 Shire 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Shire Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Shire Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Shire Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Santen Pharmaceutical 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Santen Pharmaceutical Different Types of Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Volume in Different Applications and Its Application Share 4 USA Ophthalmic Therapeutic Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Ophthalmic Therapeutic Drugs Market Competition by Players/Manufacturers 4.1.1 USA Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Ophthalmic Therapeutic Drugs Sales and Revenue by Type 4.2.1 USA Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Ophthalmic Therapeutic Drugs Sales and Revenue by Application 4.3.1 USA Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Ophthalmic Therapeutic Drugs Sales (K Units) by Application 5 Northeast Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 5.1 Northeast Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 5.1.1 Northeast Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 5.3 Northeast Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 6 Midwest Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 6.1 Midwest Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 6.1.1 Midwest Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 6.3 Midwest Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 7 South Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 7.1 South Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 7.1.1 South Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 South Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 7.3 South Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 8 West Ophthalmic Therapeutic Drugs (Sales, Revenue and Price) 8.1 West Ophthalmic Therapeutic Drugs Sales and Value (2012-2017) 8.1.1 West Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 West Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Type 8.3 West Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Ophthalmic Therapeutic Drugs Market Forecast (2018-2023) 12.1 USA Ophthalmic Therapeutic Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Ophthalmic Therapeutic Drugs Price and Trend Forecast (2018-2023) 12.2 USA Ophthalmic Therapeutic Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Ophthalmic Therapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Ophthalmic Therapeutic Drugs Sales Forecast by Type (2018-2023) 12.3.2 USA Ophthalmic Therapeutic Drugs Revenue Forecast by Type (2018-2023) 12.3.3 USA Ophthalmic Therapeutic Drugs Price Forecast by Type (2018-2023) 12.4 USA Ophthalmic Therapeutic Drugs Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Ophthalmic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Ophthalmic Therapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Ophthalmic Therapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Ophthalmic Therapeutic Drugs Table USA Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 Table USA Ophthalmic Therapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Ophthalmic Therapeutic Drugs by Applications in 2017 Figure Hospital Pharmacies Examples Figure Online Pharmacies Examples Figure Independent Pharmacies & Drug Stores Examples Table USA Market Ophthalmic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure South Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure West Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure USA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Ophthalmic Therapeutic Drugs Table Industry News List of Ophthalmic Therapeutic Drugs Figure Industry Chain Structure of Ophthalmic Therapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Ophthalmic Therapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs Table Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Ophthalmic Therapeutic Drugs Table Bayer Basic Information List Table Bayer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Bayer Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Bayer Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Bayer Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Bayer Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Pfizer Basic Information List Table Pfizer Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Pfizer Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Pfizer Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Pfizer Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Novartis Basic Information List Table Novartis Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Novartis Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Novartis Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Novartis Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table ALLERGAN Basic Information List Table ALLERGAN Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure ALLERGAN Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure ALLERGAN Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure ALLERGAN Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ALLERGAN Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table ALLERGAN Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table ALLERGAN Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Aerie Pharmaceuticals Basic Information List Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Valeant Pharmaceuticals International Basic Information List Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Genentech Basic Information List Table Genentech Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Genentech Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Genentech Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Genentech Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Genentech Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Genentech Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Genentech Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Regeneron Pharmaceuticals Basic Information List Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Shire Basic Information List Table Shire Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Shire Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Shire Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Shire Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Shire Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Shire Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Shire Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Company Santen Pharmaceutical Basic Information List Table Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table by Therapeutic Class Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-inflammatory Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Anti-infective Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table Company Santen Pharmaceutical Ophthalmic Therapeutic Drugs Volume in and Its Application Share Table USA Ophthalmic Therapeutic Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Ophthalmic Therapeutic Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Ophthalmic Therapeutic Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Ophthalmic Therapeutic Drugs Sales Share by Players/Manufacturers Table USA Ophthalmic Therapeutic Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Ophthalmic Therapeutic Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Ophthalmic Therapeutic Drugs Revenue Market Share (%) Players Figure 2017 USA Ophthalmic Therapeutic Drugs Revenue Market Share (%) Players Table USA Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Ophthalmic Therapeutic Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Ophthalmic Therapeutic Drugs by Type (2012-2017) Figure USA Ophthalmic Therapeutic Drugs Sales Growth Rate (%) by Type (2012-2017) Table USA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Ophthalmic Therapeutic Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Ophthalmic Therapeutic Drugs by Type (2012-2017) Figure USA Ophthalmic Therapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table USA Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table USA Ophthalmic Therapeutic Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Ophthalmic Therapeutic Drugs by Regions (2012-2017) Figure USA Ophthalmic Therapeutic Drugs Sales Market Share by Regions in 2017 Table USA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Ophthalmic Therapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Ophthalmic Therapeutic Drugs by Regions (2012-2017) Figure USA Ophthalmic Therapeutic Drugs Revenue Market Share by Regions in 2017 Table USA Ophthalmic Therapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017) Table USA Ophthalmic Therapeutic Drugs Sales Share (%) by Application (2012-2017) Figure USA Ophthalmic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure USA Ophthalmic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure Northeast Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Northeast Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Northeast Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Northeast Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Midwest Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Midwest Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Midwest Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Midwest Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure South Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure South Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table South Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table South Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table South Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure West Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure West Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table West Ophthalmic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table West Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure West Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table West Ophthalmic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table West Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure West Ophthalmic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Ophthalmic Therapeutic Drugs Price and Trend Forecast (2018-2023) Table USA Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure USA Ophthalmic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Ophthalmic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure USA Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Regions in 2023 Figure Northeast Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Ophthalmic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Ophthalmic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Type (2018-2023) Figure USA Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Type (2018-2023) Table USA Ophthalmic Therapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Ophthalmic Therapeutic Drugs Revenue Market Share Forecast by Type (2018-2023) Table USA Ophthalmic Therapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table USA Ophthalmic Therapeutic Drugs Sales (K Units) Forecast by Application (2018-2023) Figure USA Ophthalmic Therapeutic Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Bayer Pfizer Novartis ALLERGAN Aerie Pharmaceuticals Valeant Pharmaceuticals International Genentech Regeneron Pharmaceuticals Shire Santen Pharmaceutical